Alembic Pharmaceuticals Limited is one of
the leading pharmaceutical companies in India with a consolidated turnover of
over US$ 475 Million. Established in 1907, Alembic has expertise in synthetic
chemistry, formulation development and solid oral dosage form manufacturing. It
has a state-of-the-art R&D facility which focuses on API Process
Developments & Process Chemistry, Generic formulation development, Novel
Drug Delivery systems, and Bio Equivalence studies. Manufacturing facilities
are approved by USFDA, EDQM, German FDA, TGA, KFDA, MHRA, TPD, MCC, COFEPRIS
Anton Paar develops and produces high-quality measuring and analysis instruments for industrial and research applications. Founded in 1922, Anton Paar is the world leader in density, concentration and CO2 measurement and in the field of rheometry. The state-of-the-art product range also comprises small-angle X-ray scattering systems, instruments for surface characterization, viscometers, refractometers, polarimeters, microwave synthesizers, microwave digesters, petroleum testing instrumentation and a range of process instruments.
Anton Paar India Pvt. Ltd. is headquartered at Gurgaon - NCR Delhi. The sales and service centers are located in Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Vadodara, Ahmedabad and Guwahati and there are four application support centers in Gurgaon, Mumbai, Bangalore and Hyderabad.
Beijing Infoark Co Ltd, established in 1997, specializes in pharmaceuticals, intermediates, food and feed additives, veterinary, health and nutrition products. After years of rapid development, Infoark has become one of the largest and most professional suppliers in China, and grows to be an integrated company covering R&D, production and sales, with international trade as the main development direction based upon the leading high-tech R&D and production site.
Brooks Laboratories Ltd was established in 2002 and maintains its strong presence in the Pharmaceutical industry as a Contract Manufacturing Company since its inception. Brooks Laboratories Ltd is a Research and Development driven Pharmaceutical manufacturing company. In last 6 years company has successfully established itself as a reputed Contract Manufacturing company for generic products in Injectables and Amoxiillin + Clavulanic Acid range of Tablets and Dry Syrups. Brooks has recently commissioned a Brand New Dedicated Facility for Carbapenem Injections at Baroda, India, with a huge capacity of 50 million vials per annum. The New Carbapenem Facility at Baroda will also manufacture Lyophilized Carbapenem injections like Ertapenem. The new Dedicated Carbapenem Plant has been designed for Development and Supply of Injections for Europe, USA, Canada, Australia, South Africa and other Regulated Markets and also do Contract Manufacturing for Quality Conscious Pharmaceutical companies for Regulated and Semi Regulated Markets. Brooks can as well provide interested customers with ANDAs and Dossiers in CTD formats. The new Plant at Baroda has good capacity to cater to big markets of USA, Europe etc. The entire new plant of Carbapenems at Baroda has been designed as per the cGMP requirements of US-FDA, European GMP standards and WHO standards. The Carbapenem plant is scheduled for a European GMP audit and certification in August '2017. Interested parties for Carbapenems and other injections can contact us - [email protected]
It's a truly dynamic time for the global pharma industry, and CPhI Worldwide & P-MEC India provides an opportunity to meet the GEA team, discover the latest trends, technologies and insights and, above all else, drive new partnerships, do business and grow. By investing in and supporting these events, we're highlighting our ongoing support for the current and future pharmaceutical industry. Learn all about GEA's solutions for the Solid-Pharma, Liquid-Pharma and Bio-Pharma industries. Get ‘hands on' with our equipment for batch and continuous productions and take part in "live" demonstrations and meet all our experts from every sector of the pharmaceutical market in one place.
Innophos is a leading international producer of
specialty ingredient solutions that deliver far-reaching, versatile benefits
for the food, health and nutrition markets. We leverage our expertise in the
science and technology of formulating and blending to help our customers offer
products that are tasty, healthy, nutritious and economical.
Lesaffre Human Care was created
in 2007 as a business unit of Lesaffre with the mission to develop and supply
ingredients from yeast and bacteria fermentation to the global human care
markets. With the support of the company's unique know-how as well as more than
160 years of experience in biotechnology and yeast research and manufacturing,
Lesaffre Human Care offers ingredients with scientifically proven efficacy to
the nutritional supplements, pharmaceuticals and functional foods industry.
From nutritional and fortified yeasts to yeasts fractions, probiotic yeasts and bacteria, or pure molecules from fermentation, Lesaffre Human Care has solutions for a wide range of applications such as digestive health, immunity enhancement, women's health, joints and liver health, mood management, vegetarian support, overall wellbeing and beauty.
For further information, visit www://lesaffrehumancare.com
Certifications: EU-GMP, WHO-GMP, and Jordan FDA
USPs of our product:
1. We are 100% EOU zone.
2. Accredited by European Union for GMP Compliances.
3. Total Aqueous based.
4. Dissolution Profile matches to the innovator product
Audited and approved by:
4. Sandoz etc.
Nanjing Pharmacare Co Ltd is a leading supplier of pharmaceutical products, including formulations, APIs, health product and empty gelatin capsules. We have professional team from R&D, Regulatory affairs, BD to logistics. Our core competition includes continuous supply of new generics, GMP pre-audit and CTD dossier on both formulations and APIs.
Next Wave (India) is a WHO-GMP approved Pharmaceutical company. The company has state of the art facility to manufacture non betalactum finished dosage forms of Tablets, Oral Liquids, Capsules and Gels, Ointments & Creams.The company is reputed CDMO with independent facility to develop new products as per regulatory requirements. The company offers manufacturing capabilities for Indian and Global markets and has its own presence in various countries of SEA, LATAM and Africa region.
"Optimus is a unique API, Advance Intermediates and Formulations/pellets manufacturer. Optimus is approved and admired by many regulatory authorities and customers globally. We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry."
Optimus is a Hyderabad, India based company, we are approved by US FDA, EU GMP, COFEPRIS MEXICO, KFDA, WHO GENEVA and ISO. We have our business footprint in most of the global regions like LATAM, US, EU, MENA, CIS/RUSSIA, ASIA & INDIA.
MAKING LIFE BETTER! The safety of your patients is your first objective. That's why the quality and stability of your formulations are your ultimate challenge, and ours too. As a long-established global provider of plant-based excipients and life-saving active ingredients for the pharmaceutical and biopharmaceutical industries, Roquette offers a competitive broad-range of customers focused solutions. Visit us at stand #8F30!
SPI Pharma is a global leader serving over 55 countries in the manufacture and marketing of antacid actives, excipients, drug delivery systems for tablets, fast-dissolve technologies, chewables, lozenges, and a variety of other patient-friendly dosage formats. SPI also specializes in drug development services, delivering in-vitro data packages in CTD Module 3 format. SPI's primary objective is to engineer functional materials that enable our customers to solve formulation problems, achieve differentiation, and gain speed to market. This is accomplished by establishing a leading position in functional materials and collaborating with our customers to deliver value-added and cost-effective solutions to their problems.
SYNOKEM PHARMACEUTICALS LTD; with an experience of 34 years in the pharmaceutical arena; has achieved various landmarks and known in the market for its high standard quality and timely deliveries; which made it renowned among all big companies for strategic partnership / association for CMS as well as new molecule innovations in FDFs.
SYNOKEM Pharma, is among top 3 largest and well known manufacturer of Hormonal (oral) FDFs in india and having 2 WHO GMP approved and international accredited plants in northern part of india. Soonest Synokem plants will be PICs approved as well.
Whereas for general segment of FDFs (tablets / capsules / oral suspension); Synokem Pharma has got huge production capacity and production goes on 3 shifts a day and 24x7 whole year. The overseas venture of Synokem has also grown simultaneously and now presence of its brands is increasing in CIS / SEA / Africa and Latam markets. The next targeted market for Synokem Pharma is regulated market and looking forward for strategic alliance for growth and product promotion.
Ultratech India Limited is a GMP & ISO certified manufacturer of Active Pharmaceutical Ingredients and Finished Formulations (Tablets, Capsules, Syrups, Nasal Sprays, Injectables, Dry powder & Metered Dose Inhalers) that caters to worldwide pharma markets. Our products are ready with DMF's and Product Dossiers.
Vital Therapeutics & Formulations Pvt Ltd is one of the most successful companies in the area of Contract Manufacturing of Formulations. Our State-of-the-art manufacturing facilities with high production capacities meeting global regulatory requirements made us the preferred production location for Global MNC's.
As a contract manufacturing and packaging site for pharmaceuticals and dietary supplements we can do a lot for you:
Zim provides innovative drug delivery solutions targeting patient
convenience and adherence. It uses proprietary technologies (modified release
and taste masking), to develop and manufacture differentiated pharmaceutical
We offer oral solid dosage formulations and pre-formulations (PFI) covering tablets, capsules, dry syrups, pellets, granules and orally disintegrating strips (ODS).
A) Site transfer/variation
Ø Tablets- Sustained Release, Oral Disintegrating, fast disintegrating
Ø Capsule- Modified release - Pellets, Pellets + powder
B) Co-Development and Technology Transfer - for Sustained & Modified Release formulations including non-infringing approaches. (Also method development and validations on contract basis).
C). pilot level Cgmp batch Scale-Up and commercial level scale up services.
D) Pre-formulation products in Bulk;Pellet - Modified releaseDirectly Compressible Granules - Immediate & Sustained releaseTaste Masked granules for suspension